Krilogy Financial’s Insmed INSM Stock Holding History

Krilogy Financial’s Portfolio INSM Stock Details INSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-200	Closed	-$4K	–	384
2018 Q3	$4K	Buy	+200	New	+$4.52K	﹤0.01%	645
2017 Q4	–	Sell	-200	Closed	-$6K	–	802
2017 Q3	$6K	Hold	200	–	–	﹤0.01%	630
2017 Q2	$3K	Hold	200	–	–	﹤0.01%	639
2017 Q1	$3K	Hold	200	–	–	﹤0.01%	626
2016 Q4	$3K	Hold	200	–	–	﹤0.01%	626
2016 Q3	$3K	Hold	200	–	–	﹤0.01%	639
2016 Q2	$2K	Hold	200	–	–	﹤0.01%	680
2016 Q1	$3K	Buy	+200	New	+$2.63K	﹤0.01%	582
2015 Q4	–	Sell	-200	Closed	-$4K	–	504
2015 Q3	$4K	Buy	+200	New	+$4.99K	﹤0.01%	486

Other funds holding INSM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

FCMI

Foresite Capital Management IV Larkspur, California $290M AUM 143.88% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

VOYA Investment Management Atlanta, Georgia $116B AUM 61.47% 1-Year Est. Return

Krilogy Financial's INSM Position: Q4 2018 in Review

Krilogy Financial sold out of Insmed (INSM) in Q4 2018, closing a stake of 200 shares — an estimated $4K sold.

Krilogy Financial first reported a position in INSM in Q3 2015 and held it in 9 quarters. The position peaked at $6K in Q3 2017. 126 funds tracked by Wall St. Rank hold INSM as of Q4 2018.

Krilogy Financial reported no remaining Insmed position as of Q4 2018 after selling out during the quarter.
Krilogy Financial sold 200 Insmed shares in Q4 2018, an estimated $4K.
Krilogy Financial first reported a position in Insmed in Q3 2015 and held it in 9 quarters.
Krilogy Financial's Insmed position peaked at $6K in Q3 2017.
126 funds tracked by Wall St. Rank held Insmed as of Q4 2018.

Based on Krilogy Financial's 13F filing for Q4 2018, filed 14 Feb 2019.